Genetic Diversity, Antimicrobial Resistance, and Virulence Factors of Enterococcus faecalis Isolates Obtained from Stool Samples of Hospitalized Patients

authors:

avatar Mitra Motallebi ORCID 1 , 2 , * , avatar Zahra Sadat Seyyedi 1 , avatar Mohammad Javad Azadchehr ORCID 2

Department of Immunology and Microbiology, Faculty of Medicine, Kashan University of Medical Sciences, Kashan, Iran
Infectious Diseases Research Center, Kashan University of Medical Sciences, Kashan, Iran

How To Cite Motallebi M, Seyyedi Z S , Azadchehr M J . Genetic Diversity, Antimicrobial Resistance, and Virulence Factors of Enterococcus faecalis Isolates Obtained from Stool Samples of Hospitalized Patients. Jundishapur J Microbiol. 2022;15(6):e121379. https://doi.org/10.5812/jjm-121379.

Abstract

Background:

Enterococcus faecalis rapidly develops resistance to different antibiotics, thereby resulting in serious nosocomial infections associated with high mortality rates and different problems in the healthcare systems.

Objectives:

This study aimed to analyze the genetic diversity, antimicrobial resistance, and virulence factors of E. faecalis isolates obtained from the stool samples of patients in a hospital in the center of Iran.

Methods:

In this cross-sectional descriptive-analytical study, 108 stool samples were collected from September 2019 to February 2020 from 108 patients hospitalized in a hospital in the center of Iran. Enterococcus faecalis isolates were detected using the ddlE gene detection technique, and antimicrobial resistance testing was performed using the disc agar diffusion method. Moreover, polymerase chain reaction was used to detect antimicrobial resistance genes and virulence factors. Genetic diversity was also analyzed by enterobacterial repetitive intergenic consensus using PCR. The BioNumerics software was used to construct a dendrogram.

Results:

Of 108 isolates, 50 samples were E. faecalis (46.2%). The prevalence of multidrug resistance among E. faecalis isolates was 62%, and most isolates were resistant to antibiotics tetracycline (70%), erythromycin (68%), and rifampin (60%). Among the E. faecalis isolates, the most prevalent antimicrobial resistance genes were ermB (96%), aph (2′′) Ia (66%), aac(6′)-Ie (40%), and ermC (30%), and the most prevalent virulence genes were gelE (78%), asa1 (74%), and esp (74%). The genetic diversity analysis showed 25 ERIC types in two major clusters (ie, clusters H and J) and eight minor clusters (ie, clusters A-G and I). There was no significant difference between clusters H and J in terms of antimicrobial resistance and resistance genes (P > 0.05). In contrast, the prevalence of the asa1 gene was significantly higher in cluster J than in cluster H (P < 0.05).

Conclusions:

This study showed the high prevalence of multidrug resistance, and high heterogeneity among the E. faecalis isolates obtained from the stool samples of hospitalized patients.

1. Background

Enterococcus faecalis is the normal flora of the gastrointestinal system of humans and animals. As an occasional pathogen, it can cause community-acquired and nosocomial infections (1). It is responsible for different nosocomial infections, particularly bacteremia, sepsis, endocarditis, wound infections, and urinary tract infections (2). Previous studies have revealed that most enterococcal infections are caused by E. faecalis strains (3, 4). Enterococcal infections are a major challenge to healthcare systems and a serious threat to patient life in Iran (5). In Iran, a study on 111 clinical Enterococcus isolates showed that 80.1% of the isolates were E. faecalis (6). Hospitalization and impaired immunity are the risk factors of E. faecalis infections (7). Moreover, antimicrobial resistance and virulence factors remarkably contribute to enterococcal infections in hospitalized patients (8). In addition to innate resistance to several antimicrobial agents, Enterococcus species can acquire high resistance to different antibiotics through the horizontal transfer of mobile genetic elements (9).

Given the wide and inappropriate use of antibiotics in clinical settings for managing community-acquired infections, the emergence of multidrug-resistant (MDR) E. faecalis strains has become a serious healthcare concern worldwide. There are limited treatment options for MDR bacterial species. Moreover, MDR species can transfer genetic antimicrobial resistance factors to other commensal bacteria in the gastrointestinal system or the environment (10). Accordingly, there are clinical challenges in managing enterococcal infections due to their progressive resistance to different antibiotics such as beta-lactams, macrolides, fluoroquinolones, glycopeptides, and aminoglycosides (11, 12).

Antimicrobial resistance to the high concentrations of aminoglycoside antibiotics is usually caused by the aminoglycoside modifying enzymes found in and encoded by mobile genetic elements. Moreover, resistance to vancomycin is encoded by the van gene clusters transferred in one transposon (13). Virulence factors such as gelatinase, aggregation substance proteins, Enterococcus surface proteins, collagen adhesion, cytolysin, and hyaluronidase play roles in bacterial adhesion, colonization, invasion, escaping from the host’s immune response, extracellular enzyme production, virulence, and infection aggravation (14).

Source detection and the effective management of enterococcal nosocomial infections largely depend on determining their genetic diversity (15). Currently, different methods such as pulse-field gel electrophoresis (PFGE), restriction fragment length polymorphism (RFLP), and enterobacterial repetitive intergenic consensus using polymerase chain reaction (ERIC-PCR) have been used for the epidemiological assessment of bacteria (16, 17). ERIC-PCR is a popular molecular analysis method for typing Enterococcus isolates. The ERIC sequences are the imperfect palindromes of 127 base pairs (bp); however, the ERIC region can be smaller or larger due to internal eliminations or the entrance of larger sequences. The ERIC sequences were first detected in Escherichia coli, Salmonella typhimurium, other Enterobacteriaceae members, and Vibrio cholerae. However, it has recently been revealed that they are present in other species and can be used for typing (18). In Indonesia, a study showed that all E. faecalis isolates analyzed by the Eric typing method had >60% similarity and were in five clusters (19).

Several studies in different countries reported the great antimicrobial resistance and the great genetic diversity of Enterococcus species (20-22). A study on Enterococcus isolates obtained from the stool samples of children in the northwest of Iran showed great antimicrobial resistance to tetracycline, rifampin, and erythromycin and great genetic diversity among the E. faecalis isolates (23). The genetic pattern of Enterococcus species such as E. faecalis varies not only in different areas but also in a single setting; hence, there may be multiple clusters specific to a single area or setting.

2. Objectives

Studying the epidemiology of E. faecalis can provide valuable information about the current and future status of nosocomial infections. The present study aimed to analyze the genetic diversity, antimicrobial resistance, and virulence factors of E. faecalis isolates obtained from the stool samples of patients in a hospital in the center of Iran.

3. Methods

3.1. Sampling and Enterococcus faecalis Detection

This cross-sectional descriptive-analytical study was conducted from September 2019 to February 2020. The non-duplicated stool samples were obtained from patients hospitalized for at least three days in the internal medicine ward, infectious diseases ward, and coronary care unit of the Shahid Beheshti Hospital, Kashan, Iran. The isolates were cultured in the laboratory of the Microbiology Department of the Kashan University of Medical Sciences, Kashan, Iran. They were phenotypically detected at the species level using biochemical tests such as catalase test, culturing on the brain heart infusion broth containing 6.5% NaCl, and the Bile-Esculin test (24). The identity of the isolates was genotypically confirmed using the PCR method and the specific primer of the ddlE gene of E. faecalis (25).

3.2. Antimicrobial Resistance Testing

The antimicrobial resistance pattern of E. faecalis isolates was determined phenotypically and genotypically. In the phenotypic method, the disc agar diffusion method was used according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) to test the antimicrobial resistance of the isolates for the following 10 antibiotics: penicillin (PEN, 10 units), ampicillin (AMP, 10 µg), ciprofloxacin (CIP, 5 µg), erythromycin (E, 15 µg), tetracycline (TET, 30 µg), nitrofurantoin (NI, 300 µg), rifampin (RI, 5 µg), quinupristin-dalfopristin (SYN, 15 µg), and linezolid (LZD, 5 µg). First, a 0.5 McFarland microbial suspension of the isolates was prepared. After culturing the isolates, the inhibition zone diameter was measured and interpreted based on the CLSI table (26). According to the recommendations of the CLSI, Staphylococcus aureus ATCC 25923 was used as a control to standardize the antimicrobial resistance test. Isolates resistant to at least three antibiotic classes were considered as MDR.

3.3. DNA Extraction

DNA extraction was performed using the DNA TIANamp extraction kit (TIANGEN Biotech, Beijing, China). The spin column in this kit is made of a silica membrane, which can attach to and detach from DNA under specific pH and salt conditions. The DNA concentration was measured using a NanoDrop spectrophotometer (Thermo Fisher Scientific, USA).

3.4. Detection of the Antimicrobial Resistance and the Virulence Genes

The PCR method was employed to genotypically detect the genes responsible for resistance to antibiotics vancomycin (vanB, vanA), aminoglycosides (aac(6′)-Ie aph(2′′)Ia), and macrolides (ermA, ermB, ermC) (Table 1). To this end, specific primers and the method described in our previous work (27) were used. Moreover, E. faecalis isolates were assessed for the virulence genes efa, ace, asa1, gelE, hy1, cy1A, and esp using specific primers and PCR conditions, as explained in Table 2.

Table 1.

PCR Conditions and Primers for Amplifying Antimicrobial Resistance Genes of Enterococcus faecalis Isolates Obtained from Hospitalized Patients’ Stool Samples

Target GenePrimersOligonucleotide Sequence 5'-3'Size of Amplified Product (bp)Annealing Temperature
vanAFGGGAAAACGACAATT GC73254°C
RGTA CAATGC GGCCGTTA
vanBFATGGGAAGCCGATAGTC638
RGATTTCGTTCCTCGACC
aac(6′)-IeFAGGAATTTATCGAAAATGGTAGAAAAG36954°C
RCACAATCGACTAAAGAGTACCAATC
aph(2′′)IaFCAAACTGCTAAATCGGTAGAAGCC294
RGGAAAGTTGACCAGACATTACGAACT
ermAFTAT CTT ATC GTT GAG AAG GGA TT13955°C
RCTA CAC TTG GCT GAT GAA A
ermBFCTA TCT GAT TGT TGA AGA AGG ATT142
RGTT TAC TCT TGG TTT AGG ATG AAA
ermCFAAT CGT CAA TTC CTG CAT GT299
RTAA TCG TGG AAT ACG GGT TTG
Table 2.

PCR Plan and Primers for Amplification of Virulence Genes of Enterococcus faecalis Isolates Obtained from Hospitalized Patients’ Stool Samples

Target GenePrimersOligonucleotide Sequence 5'-3'Size of Amplified Product (bp)Annealing Temperature
asa1FGCACGCTATTACGAACTATGA37556°C
RTAAGAAAGAACATCACCACGA
espFAGATTTCATCTTTGATTCTTG51056°C
RAATTGATTCTTTAGCATCTGG
hylFACAGAAGAGCTGCAGGAAATG27656°C
RGACTGACGTCCAAGTTTCCAA
gelEFTATGACAATGCTTTTTGGGAT21356°C
RAGATGCACCCGAAATAATATA
cylAFGACTCGGGGATTGATAGGC68856°C
RGCTGCTAAAGCTGCGCTTAC
aceFGGAATGACCGAGAACGATGGC61658°C
RGCTTGATGTTGGCCTGCTTCCG
efaAFCGTGAGAAAGAAATGGAGGA49958°C
RCTACTAACACGTCACGAATG

3.5. ERIC Typing

Genetic diversity was assessed using ERIC-PCR, as described by Versalovic et al. (28). The ERIC region was detected using the ERIC1R (5'-ATG TAA GCT CCT GGG GAT TCAC-3') and the ERIC2 (5'-AAG TAA GTG ACT GGG GTG AGC G-3') primers (Metabion, Germany). Moreover, the ERIC region was amplified using a 25-µL mixture of sterile distilled water (18 µL), 10X PCR buffer (2.5 µL), dNTP (1 µL of 10 molars), ERIC1R and ERIC2 primers (1 µL of each), Taq polymerase (0.5 µL), and template DNA (1 µL). The PCR reaction consisted of initial denaturation at 95°C for three minutes accompanied with 35 warming cycles, each of which consisted of denaturation at 94°C for one minute, annealing at 48°C for one minute, extension at 72°C for two minutes, and final extension at 72°C for five minutes (29).

3.6. ERIC Analysis

The band profile analysis was done with BioNumerics software version 8.0. The dendrogram was constructed by the genetic diversity analysis using the Unweighted Pair Group Mean Method with Arithmetic mean (UPGMA), disc similarity coefficient, and 1% band position tolerance. According to the ladder, only the bands with a length of 100 - 3000 bp were included in the analysis. The BioNumerics software creates groups with a specific similarity range. The differences between band profiles in the dendrogram were depicted using the digits above lines (Figure 1). For the band analysis, the isolates with a genetic similarity of at least 80% were grouped as an ERIC type; however, the isolates not having such a similarity were considered as separate ERIC types and then labeled as ERIC E1–En. ERIC clustering criteria in the BioNumerics software were a difference of ≤ 20% and the presence of more than one isolate in each cluster.

Dendrogram constructed based on fingerprint of ERIC regions of fifty Enterococcus faecalis isolates. According to a dice coefficient similarity of at least 80%, the E. faecalis isolates were clustered into ten clusters (ie, clusters A–J).
Dendrogram constructed based on fingerprint of ERIC regions of fifty Enterococcus faecalis isolates. According to a dice coefficient similarity of at least 80%, the E. faecalis isolates were clustered into ten clusters (ie, clusters A–J).

3.7. Statistical Analysis

The collected data was analyzed with SPSS software version 22.0. Values were reported as relative frequency. The chi-square test was used for frequency comparison at P < 0.05.

4. Results

4.1. Characteristics of Patients and Isolates

The phenotypic and genotypic tests were used, and fifty E. faecalis isolates were obtained from 108 stool samples (46.2%). None of the samples was duplicated. The E. faecalis isolates were obtained from an internal medicine ward (n = 22), an infectious diseases ward (n = 16), and a coronary care unit (n = 12). The Enterococcus faecalis isolates were obtained from both male (n = 29) and female (n = 21) patients. The participants’ mean age was 65.1 ± 15.4 years (Table 1).

4.2. Antimicrobial Resistance Testing

The antimicrobial resistance testing results showed that the great resistance of the E. faecalis isolates to the antibiotics TET (70%), E (68%), RI (60%), SYN (48%), and CIP (48%). Table 3 shows the antimicrobial resistance of E. faecalis isolates to the ten tested antibiotics. Thirty-one E. faecalis isolates (62%) were MDR. In this regard, MDR had no significant relationship with patients’ gender, age, length of hospital stay, and hospitalization ward (P > 0.05). The Enterococcus faecalis isolates showed the highest antimicrobial susceptibility to the antibiotics LZD (94%), NI (86%), AMP (78%), and PEN (76%).

Table 3.

Participants’ Characteristics and Enterococcus faecalis Isolates’ Antimicrobial Resistance, Virulence Genes, and Genotypes

No.GenderAge (y)WardHospital Stay (d)Resistance PatternsResistance GenesMDRVirulence GenesERIC TypeCluster
1Female60IM5_ermB, ermC, aac(6′)-Ieasa1, esp, gelEE25J
2Female84CCU4E+SYN+TETermB, aph(2′′)Ia+asa1, espE24I
3Female63IM7RI+E+SYN+PEN+CIPermB, aph(2′′)Ia+asa1, esp, gelEE25J
4Female56IM3E+SYN+TET +CIPermB, aac(6′)-Ie, aph(2′′)Ia+asa1, esp, gelEE24I
5Male65IM6RI+E+SYN+CIPermB, ermC, aph(2′′)Ia+asa1, gelEE23H
6Female70IM3RI+E+PEN+TET+CIP+AMPvanA, ermB+asa1, espE18
7Female75IM6E+SYNermBgelEE6
8Male82CCU4RI+SYN+CIPermB, aac(6′)-Ie+E1
9Male74IM5RI+E+SYN+PEN+TET+CIP+AMPermB, aac(6′)-Ie, aph(2′′)Ia+asa1, gelEE23H
10Female78CCU3SYN+TETermB, ermC, aph(2′′)IacylA, asa1, esp, gelEE4
11Female66IM3RI+E+SYN+TET+CIPermA, ermB, aac(6′)-Ie, aph(2′′)Ia+asa1, esp, gelEE25J
12Male55IM3_ermB, ermC, aac(6′)-Ie, aph(2′′)IaespE11
13Female17CCU3TETvanA, ermB, aac(6′)-Ie, aph(2′′)IacylA, asa1, esp, gelEE10B
14Female67CCU3E+NI+TETermB+asa1, espE10B
15Male48CCU3RI+E+SYN+TETermB+asa1, esp, gelEE23H
16Male86CCU7E+TETermB, aph(2′′)Iaesp, gelEE21G
17Male83CCU3TETermBcylA, asa1, esp, gelEE15D
18Female80IM4_ermBgelEE15D
19Female59IM3RI+E+PEN+TET+CIP+AMPvanA, ermB, aph(2′′)Ia+cylA, asa1, esp, gelEE14C
20Female59IM4_ermBcylA, asa1E15D
21Female79CCU4_vanA, ermB, aph(2′′)IacylA, asa1, esp, gelEE14C
22Female86IM5TETermB, aph(2′′)IagelEE23H
23Male75ID4E+CIPermB, aph(2′′)Iaasa1, esp, gelEE5
24Male41IM3E+TETermBcylA, asa1, espE3
25Female54IM3RI+E+PEN+TET+CIP+AMPermB, ermC, aac(6′)-Ie+asa1, esp, gelEE22
26Male42IM3TET_cylA, asa1, esp, gelEE16E
27Female78IM5E+CIPermB, aph(2′′)Iaasa1, espE16E
28Female45ID6RI+E+CIPermB, aph(2′′)Ia+cylA, asa1, esp, gelEE17
29Female77IM4RI+E+TETermB, aph(2′′)Ia+cylA, asa1, esp, gelEE13
30Male44ID8RI+E+SYN+TET+CIPermB, aph(2′′)Ia+asa1, esp, gelEE8A
31Female43ID10RI+TETermA, ermB, ermC, aph(2′′)Iaasa1, esp, gelEE21G
32Male51ID6RI+SYNermB, ermC, aac(6′)-Ie, aph(2′′)Iaasa1, esp, gelEE7A
33Male53CCU5RI+E+SYN+NI+PEN+TET+CIP+AMPvanA, ermB, ermC aac(6′)-Ie, aph(2′′)Ia+asa1, esp, gelE, hylE8
34Male73ID7RI+E+LZD+NI+PEN+TET+CIP+AMPermB, aac(6′)Ie, aph(2′′)Ia+asa1, esp, gelEE2
35Male54ID4RI+SYN+TETermB, ermC, aac(6′)-Ie, aph(2′′)Ia+asa1, espE25J
36Male68ID5RI+EermB, aac(6′)Ie, aph(2′′)Iaasa1, esp, gelEE20F
37Male49ID4RI+E+SYN+TETermA, ermB, ermC, aac(6′)Ie+asa1, esp, gelEE20F
38Male80ID3RI+E+SYN+NI+PEN+TET+CIP+AMPvanA, ermA, ermB, ermC, aac(6′)Ie, aph(2′′)Ia+esp, gelEE19
39Male71ID3RI+E+SYN+NI+PEN+TET+CIP+AMPvanA, ermB, ermC, aac(6′)Ie, aph(2′′)Ia+asa1, esp, gelEE25J
40Male65ID3RI+E+SYN+TETermB, aac(6′)Ie+asa1, esp, gelEE9
41Male90IM5RI+NI+TET+CIPermB+E25J
42Male52ID7RI+TETermA, ermB, ermC, aac(6′)Ie, aph(2′′)Iaasa1, esp, gelEE25J
43Male71ID3RI+E+ PEN+CIP+AMPvanA, ermA, ermB, ermC, aac(6′)Ie, aph(2′′)Ia+asa1, esp, gelEE25J
44Male89ID3RI+E+SYN+PEN+TET+CIP+AMPermB, aac(6′)Ie, aph(2′′)Ia+asa1, esp, gelEE25J
45Male65IM6E+SYN+ TET+CIPermB, aph(2′′)Ia+asa1, gelEE25J
46Male80IM3RI+E+SYN+ TET+CIPvanA, ermB, aph(2′′)Ia+esp, gelEE23H
47Male45ID4RI+E+SYN+PEN+TET+CIP+AMPermA, ermB, ermC, aac(6′)Ie, aph(2′′)Ia+_E23H
48Male73IM4RI+E+LZD+SYN+NI+TETermB+gelEE23H
49Female63CCU3E+SYN+TET+CIPvanA, ermB, aph(2′′)Ia+gelEE12
50Male73CCU3RI+E+LZD+TET_+gelEE23H

4.3. Antimicrobial Resistance Genes

The analysis of antimicrobial resistance genes among the E. faecalis isolates indicated that the most prevalent genes were ermB (96%), aph(2′′)Ia (66%), aac(6′)-Ie (40%), ermC (30%), vanA (20%), and ermA (14%). Moreover, the most prevalent antimicrobial resistance patterns were ermB+ aph(2′′)Ia (20%), ermB (18%), and ermB+aac(6′)-Ie+ aph(2′′)Ia (10%).

4.4. Virulence Genes

The virulence gene analysis of the E. faecalis isolates showed that the most prevalent genes were gelE (78%), asa1 (74%), and esp (74%), and that the prevalence rates of the cylA and hyl genes were low (20% and 2%, respectively). Moreover, the most prevalent virulence gene patterns were asa1+esp+gelE (36%) and cylA+asa1+esp+gelE (16%).

4.5. Genetic Diversity Analysis

The genetic diversity analysis by ERIC-PCR revealed 25 genotypes among fifty E. faecalis isolates (E1–E25), which consisted of fifteen genotypes with a genetic similarity of at least 80% and ten genotypes with a genetic similarity of < 80%. Each of the fifteen genotypes was placed in an ERIC type (Figure 1). The dendrogram analysis revealed that most E. faecalis isolates (n = 35) were clustered into ten clusters (ie, clusters A–J). Eighteen isolates were further clustered into two major clusters: cluster H with eight isolates and cluster J with ten isolates. The remaining seventeen isolates were clustered into eight minor clusters: A, B, C, D, E, F, G, and I, each with 2 - 3 isolates (Figure 1).

The antimicrobial resistance analysis in the two major clusters H and J revealed the greatest resistance to the antibiotics E, RI, and TET. Moreover, the antimicrobial resistance gene analysis also revealed that the most prevalent genes in cluster H were ermB (87%) and aph(2 ′′)Ia (62.5%). In comparison, the most prevalent genes in cluster J were ermB (100%), aph(2′′)Ia (80%), and aac(6′)-Ie (70%). However, Fisher's exact test indicated no significant difference between clusters H and J in terms of antimicrobial resistance and resistance genes. The virulence gene analysis also suggested that the most prevalent genes in cluster H were gelE (100%) and asa1 (37.5%), and the most prevalent genes in cluster J were asa1 (90%), gelE (80%), and esp (80%). The prevalence of the asa1 gene was significantly higher in cluster J than in cluster H (P < 0.05).

5. Discussion

This study analyzed the genetic diversity, antimicrobial resistance, and virulence factors of E. faecalis isolates obtained from the stool samples of patients in a hospital in the center of Iran. In this study, fifty E. faecalis isolates were obtained from 108 stool samples. In other words, the prevalence of E. faecalis isolates was 46.2%. This prevalence rate exceeds the rate reported in a study in China (15%) and is below the rate reported in a study in Brazil (70%) (30). Several recent studies reported that the prevalence of E. faecalis isolates among clinical Enterococcus isolates was 28 - 70% (5, 31, 32). This difference in the prevalence of E. faecalis isolates in these studies can be due to the differences among clinical settings regarding their infection control policies.

The findings showed that the 62-percent prevalence rate of MDR patterns among the E. faecalis isolates. Antimicrobial resistance among enterococcal serotypes is a major public health concern worldwide (33). A study in Iran showed that 29% of the E. faecalis isolates obtained from urinary tract infections were MDR (34). Another study at the Shahid Beheshti Hospital, Kashan, Iran, reported that the prevalence rate of 37.7% for the MDR E. faecalis isolates obtained from clinical samples (35). The higher prevalence of MDR among the E. faecalis isolates in our study denotes the high risk of enterococcal nosocomial infections in the study setting. The MDR isolates cause treatment failure and are associated with a higher mortality rate compared wo the non-MDR isolates (36). Factors such as healthcare exposure, shortage of diagnostic equipment, lack of surveillance systems, and the wide and inappropriate use of antibiotics can contribute to the emergence and spread of antimicrobial resistance, the acquisition of antimicrobial resistance genes, and the transfer of these genes. These factors might also have resulted in the high prevalence of antimicrobial resistance in the present study.

The research findings also revealed great antimicrobial resistance to antibiotics TET (70%), E (68%), and RI (63%) among the E. faecalis isolates obtained from the stool samples of hospitalized patients. This is in line with the findings of previous studies in Iran (37), Greece (38), and China (39). However, studies in India (40) and Brazil (41) reported lower antimicrobial resistance to these antibiotics. The use of over-the-counter antibiotics for infection management and agriculture may be the reasons for great resistance to antibiotics such as TET in Iran. Most E. faecalis isolates in the present study were susceptible to LZD. In Spain, a study showed that 100% of the E. faecalis isolates were susceptible to LZD and AMP (42). Another study in our setting also reported that the antimicrobial susceptibility of the E. faecalis isolates to antibiotics LZD and AMP was 100% and 88%, respectively (35). Nonetheless, our findings showed three LZD-resistant isolates, and the susceptibility of the E. faecalis isolates was 94% to LZD and 78% to AMP, which are slightly smaller than the rates reported in the aforementioned study.

The antimicrobial resistance gene analysis in the present study showed that the most prevalent genes were ermB (96%), aph(2′′)Ia (66%), aac(6′)-Ie (40%), ermC (30%), vanA (20%), and ermA (14%). Genetic antimicrobial resistance attributes are either innate or acquired and can be transferred to other isolates (10). A mechanism for cross-resistance to macrolide-lincosamide-streptogramin among E. faecalis isolates is to change the target site of the antibiotic erythromycin, which is mediated by the ermB gene (43). The high prevalence of this gene in the present study is in line with the findings of studies in the United States, China, South Korea, and Saudi Arabia (43). However, the prevalence of the ermA gene in the present study was 14%.

This finding is in contrast with the findings of former studies, which reported that above 90% of E. faecalis isolates had the ermA gene (44, 45). The prevalence rates of the aph(2′′)Ia and aac(6′)-Ie genes in the present study were 66% and 40%, respectively. These genes encode the 6-aminoglycoside acetyltransferase and 2-aminoglycoside phosphotransferase enzymes found in most aminoglycoside-resistant Enterococcus species. The incidence of these aminoglycoside-resistant genes has been increased in recent years (46). Enterococcus species with these genes have great antimicrobial resistance; hence, they, can escape antimicrobial mechanisms and cause infection in their hosts.

The prevalence rates of the vanA and the vanB genes in the E. faecalis isolates were 20% and 0%, respectively. The emergence of vancomycin-resistant Enterococcus species and the limited treatment options for their management have become a major clinical and epidemiological concern since afflicted patients experience more complications and higher treatment costs. Nine types of cluster genes encode vancomycin resistance, among which vanAvanN. vanA and vanB are the most important and prevalent genes in vancomycin-resistant Enterococcus species (45). Genetic factors such as plasmids, integrons, and transposons contribute to the emergence, transfer and the spread of antimicrobial resistance genes, particularly in Enterococcus species, thereby resulting in treatment failure (47).

The virulence gene analysis in the present study also revealed that the most prevalent virulence genes were gelE (78%), asa1 (74%), and esp (74%), followed by the less prevalent genes of cylA (20%) and hyl (2%). These findings documented that most E. faecalis isolates carried the gelE, asa1, and esp genes. A previous study on clinical E. faecalis isolates in Shiraz, Iran, showed that the prevalence rates of the asa1, esp, gelE, cylA, and hyl genes were respectively 100%, 94.1%, 80.4%, 64.7%, and 51% (47), respectively. The reported rates are higher than the rates obtained in our study. Moreover, the prevalence of the asa1 gene was higher in the present study than in some previous studies (48-50).

The high prevalence of the asa1 gene in the present study can facilitate the exchange of virulence and antimicrobial resistance genes in our setting. The second most prevalent genes in the present study were the asa1 and esp genes, with a prevalence rate of 74%. The high prevalence of the esp gene in our study is in line with the findings of some other studies (51-53). Moreover, our findings showed that the E. faecalis isolates carried more virulence genes compared to the prevalence reported in some previous studies (18, 28, 48, 54, 55). This difference may be due to the differences in the participants’ characteristics and geographical dispersion. Considering the remarkable role of virulence factors in the adhesion, colonization, and biofilm formation ability of bacteria, the high prevalence of Enterococcus species which carry virulence factors can be associated with more severe infections (47).

The genetic diversity analysis revealed 25 ERIC types, and the dendrogram analysis showed that most E. faecalis isolates (n = 35) were clustered into ten clusters (ie, clusters A-J). These clusters were further clustered into two major clusters H with eight isolates and J with ten isolates, as well as eight minor clusters, each with 2 - 3 isolates. These findings can imply epidemiological relations among some circulating MDR E. faecalis isolates in the study setting. Moreover, the genetic diversity analysis showed great genetic diversity among the isolates not included in the two major clusters. Great genetic diversity among the isolates can improve the survival of different E. faecalis strains in the study setting. Several studies in Iran and other countries have also reported the genetic diversity of the E. faecalis isolates. For example, a study in Isfahan, Iran, found fourteen ERIC types among 53 E. faecalis isolates (45). Another study in Indonesia showed that all E. faecalis isolates had > 60% similarity and reported five clusters (19). Moreover, a study on patients with burn injuries in Tehran, Iran, found 34 ERIC types among 57 Enterococcus isolates (18). These contradictory findings can be attributed to the high heterogeneity of E. faecalis due to differences in its nucleotide sequence.

The antimicrobial resistance analysis in the two major clusters H and J showed the greatest antimicrobial resistance to antibiotics E, RI, and TET. However, there was no significant difference between these two clusters in terms of the phenotypic and the genotypic patterns of antimicrobial resistance. However, the prevalence of the asa1 virulence gene was significantly higher in cluster J than in cluster H. Different bacterial colonies may have different virulence genes and factors; hence, they can pose more problems in managing their associated infections. Given the critical role of virulence factors in the virulence of E. faecalis, the high prevalence of these strains can complicate patients' conditions. One of the limitations of this study was the small sample size. Moreover, the study was conducted in one hospital, which resulted in not having enough bacterial isolates in all clusters. Further studies are recommended to address larger sample sizes and several hospitals.

5.1. Conclusions

This study showed the high prevalence of MDR and antibiotic resistance to antibiotics E, RI, and TET among the E. faecalis isolates obtained from the stool samples of patients in a hospital in the center of Iran. Most E. faecalis isolates were susceptible to LZD. The most prevalent antimicrobial resistance genes were ermB, aph(2′′)Ia, and aac(6′)-Ie, while the most prevalent virulence genes were gelE, asa1, and esp. The ERIC-PCR analysis also revealed that the isolates were relatively heterogeneous as such they were clustered into two major and eight minor clusters with no significant difference between the two major clusters in terms of the phenotypic and genotypic patterns of antimicrobial resistance and virulence genes.

References

  • 1.

    Ramos S, Silva V, Dapkevicius MLE, Igrejas G, Poeta P. Enterococci, from harmless bacteria to a pathogen. Microorganisms. 2020;8(8). [PubMed ID: 32722391]. [PubMed Central ID: PMC7463792]. https://doi.org/10.3390/microorganisms8081118.

  • 2.

    Ferede ZT, Tullu KD, Derese SG, Yeshanew AG. Prevalence and antimicrobial susceptibility pattern of Enterococcus species isolated from different clinical samples at Black Lion Specialized Teaching Hospital, Addis Ababa, Ethiopia. BMC Res Notes. 2018;11(1):793. [PubMed ID: 30400980]. [PubMed Central ID: PMC6218977]. https://doi.org/10.1186/s13104-018-3898-0.

  • 3.

    Golob M, Pate M, Kusar D, Dermota U, Avbersek J, Papic B, et al. Antimicrobial resistance and virulence genes in Enterococcus faecium and Enterococcus faecalis from humans and retail red meat. Biomed Res Int. 2019;2019:2815279. [PubMed ID: 31211134]. [PubMed Central ID: PMC6532320]. https://doi.org/10.1155/2019/2815279.

  • 4.

    Jabbari Shiadeh SM, Pormohammad A, Hashemi A, Lak P. Global prevalence of antibiotic resistance in blood-isolated Enterococcus faecalis and Enterococcus faecium: a systematic review and meta-analysis. Infect Drug Resist. 2019;12:2713-25. [PubMed ID: 31564921]. [PubMed Central ID: PMC6731464]. https://doi.org/10.2147/IDR.S206084.

  • 5.

    Moghimbeigi A, Moghimbeygi M, Dousti M, Kiani F, Sayehmiri F, Sadeghifard N, et al. Prevalence of vancomycin resistance among isolates of enterococci in Iran: a systematic review and meta-analysis. Adolesc Health Med Ther. 2018;9:177-88. [PubMed ID: 30532606]. [PubMed Central ID: PMC6241717]. https://doi.org/10.2147/AHMT.S180489.

  • 6.

    Behnood A, Farajnia S, Moaddab SR, Ahdi-Khosroshahi S, Katayounzadeh A. Prevalence of aac(6')-Ie-aph(2'')-Ia resistance gene and its linkage to Tn5281 in Enterococcus faecalis and Enterococcus faecium isolates from Tabriz hospitals. Iran J Microbiol. 2013;5(3):203-8. [PubMed ID: 24475324]. [PubMed Central ID: PMC3895555].

  • 7.

    Farahani A. State of globe: Enterococci: virulence factors and biofilm formation. J Glob Infect Dis. 2016;8(1):1-2. [PubMed ID: 27013838]. [PubMed Central ID: PMC4785751]. https://doi.org/10.4103/0974-777X.176139.

  • 8.

    Uda A, Shigemura K, Kitagawa K, Osawa K, Onuma K, Yan Y, et al. Risk factors for the acquisition of Enterococcus faecium infection and mortality in patients with enterococcal bacteremia: a 5-year retrospective analysis in a tertiary care university hospital. Antibiotics (Basel). 2021;10(1). [PubMed ID: 33440660]. [PubMed Central ID: PMC7826794]. https://doi.org/10.3390/antibiotics10010064.

  • 9.

    Haghi F, Lohrasbi V, Zeighami H. High incidence of virulence determinants, aminoglycoside and vancomycin resistance in enterococci isolated from hospitalized patients in Northwest Iran. BMC Infect Dis. 2019;19(1):744. [PubMed ID: 31455296]. [PubMed Central ID: PMC6712822]. https://doi.org/10.1186/s12879-019-4395-3.

  • 10.

    Miller WR, Munita JM, Arias CA. Mechanisms of antibiotic resistance in enterococci. Expert Rev Anti Infect Ther. 2014;12(10):1221-36. [PubMed ID: 25199988]. [PubMed Central ID: PMC4433168]. https://doi.org/10.1586/14787210.2014.956092.

  • 11.

    Agudelo Higuita NI, Huycke MM. Enterococcal Disease, Epidemiology, and Implications for Treatment. In: Gilmore MS, Clewell DB, Ike Y, Shankar N, editors. Enterococci: From Commensals to Leading Causes of Drug Resistant Infection. Boston, Massachusetts: Eye and Ear Infirmary; 2014.

  • 12.

    Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem. 2014;6:25-64. [PubMed ID: 25232278]. [PubMed Central ID: PMC4159373]. https://doi.org/10.4137/PMC.S14459.

  • 13.

    Ahmed MO, Baptiste KE. Vancomycin-resistant enterococci: a review of antimicrobial resistance mechanisms and perspectives of human and animal health. Microb Drug Resist. 2018;24(5):590-606. [PubMed ID: 29058560]. https://doi.org/10.1089/mdr.2017.0147.

  • 14.

    Medeiros AW, Pereira RI, Oliveira DV, Martins PD, d'Azevedo PA, Van der Sand S, et al. Molecular detection of virulence factors among food and clinical Enterococcus faecalis strains in South Brazil. Braz J Microbiol. 2014;45(1):327-32. [PubMed ID: 24948952]. [PubMed Central ID: PMC4059318]. https://doi.org/10.1590/S1517-83822014005000031.

  • 15.

    Braga JFV, Leal CAG, Silva CC, Fernandes AA, Martins N, Ecco R. Genetic diversity and antimicrobial resistance profile of Enterococcus faecalis isolated from broilers with vertebral osteomyelitis in Southeast Brazil. Avian Pathol. 2018;47(1):14-22. [PubMed ID: 28737063]. https://doi.org/10.1080/03079457.2017.1359403.

  • 16.

    Motallebi M, Alibolandi Z, Aghmiyuni ZF, van Leeuwen WB, Sharif MR, Moniri R. Molecular analysis and the toxin, MSCRAMM, and biofilm genes of methicillin-resistant Staphylococcus aureus strains isolated from pemphigus wounds: A study based on SCCmec and dru typing. Infect Genet Evol. 2021;87:104644. [PubMed ID: 33246081]. https://doi.org/10.1016/j.meegid.2020.104644.

  • 17.

    Motallebi M, Jabalameli F, Beigverdi R, Emaneini M. High prevalence of direct repeat unit types of 10di, 8 h and 8i among methicillin resistant Staphylococcus aureus strains with staphylococcal cassette chromosome mec type IIIA isolated in Tehran, Iran. Antimicrob Resist Infect Control. 2019;8:50. [PubMed ID: 30886703]. [PubMed Central ID: PMC6404295]. https://doi.org/10.1186/s13756-019-0501-y.

  • 18.

    Heidari H, Emaneini M, Dabiri H, Jabalameli F. Virulence factors, antimicrobial resistance pattern and molecular analysis of Enterococcal strains isolated from burn patients. Microb Pathog. 2016;90:93-7. [PubMed ID: 26620079]. https://doi.org/10.1016/j.micpath.2015.11.017.

  • 19.

    Bachtiar EW, Bachtiar BM, Dewiyani S, Surono Akbar SM. Enterococcus faecalis with capsule polysaccharides type 2 and biofilm-forming capacity in Indonesians requiring endodontic treatment. J Investig Clin Dent. 2015;6(3):197-205. [PubMed ID: 25641820]. https://doi.org/10.1111/jicd.12143.

  • 20.

    Abriouel H, Omar NB, Molinos AC, Lopez RL, Grande MJ, Martinez-Viedma P, et al. Comparative analysis of genetic diversity and incidence of virulence factors and antibiotic resistance among enterococcal populations from raw fruit and vegetable foods, water and soil, and clinical samples. Int J Food Microbiol. 2008;123(1-2):38-49. [PubMed ID: 18180067]. https://doi.org/10.1016/j.ijfoodmicro.2007.11.067.

  • 21.

    d'Azevedo PA, Dias CA, Teixeira LM. Genetic diversity and antimicrobial resistance of enterococcal isolates from Southern region of Brazil. Rev Inst Med Trop Sao Paulo. 2006;48(1):11-6. [PubMed ID: 16547573]. https://doi.org/10.1590/s0036-46652006000100003.

  • 22.

    Daniel DS, Lee SM, Gan HM, Dykes GA, Rahman S. Genetic diversity of Enterococcus faecalis isolated from environmental, animal and clinical sources in Malaysia. J Infect Public Health. 2017;10(5):617-23. [PubMed ID: 28254461]. https://doi.org/10.1016/j.jiph.2017.02.006.

  • 23.

    Jannati E, Amirmozaffari N, Saadatmand S, Arzanlou M. Faecal carriage of high-level aminoglycoside-resistant and ampicillin-resistant Enterococcus species in healthy Iranian children. J Glob Antimicrob Resist. 2020;20:135-44. [PubMed ID: 31295581]. https://doi.org/10.1016/j.jgar.2019.06.022.

  • 24.

    Mahon CR, Lehman DC, Manuselis G. Textbook of Diagnostic Microbiology. 5th ed. New York, USA: Saunders; 2014.

  • 25.

    Yoon S, Lee YJ. Molecular characteristics of Enterococcus faecalis and Enterococcus faecium from bulk tank milk in Korea. Animals (Basel). 2021;11(3). [PubMed ID: 33801463]. [PubMed Central ID: PMC7998752]. https://doi.org/10.3390/ani11030661.

  • 26.

    Clinical Lab Standards Institute. Microbiology Standards. Clinical Lab Standards Institute; 2019. Available from: https://clsi.org/standards/products/microbiology.

  • 27.

    Emaneini M, Aligholi M, Aminshahi M. Characterization of glycopeptides, aminoglycosides and macrolide resistance among Enterococcus faecalis and Enterococcus faecium isolates from hospitals in Tehran. Pol J Microbiol. 2008;57(2):173-8. [PubMed ID: 18646406].

  • 28.

    Versalovic J, Koeuth T, Lupski JR. Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucleic Acids Res. 1991;19(24):6823-31. [PubMed ID: 1762913]. [PubMed Central ID: PMC329316]. https://doi.org/10.1093/nar/19.24.6823.

  • 29.

    Wei L, Wu Q, Zhang J, Guo W, Chen M, Xue L, et al. Prevalence and genetic diversity of enterococcus faecalis isolates from mineral water and spring water in China. Front Microbiol. 2017;8:1109. [PubMed ID: 28670302]. [PubMed Central ID: PMC5472655]. https://doi.org/10.3389/fmicb.2017.01109.

  • 30.

    Chakraborty A, Pal NK, Sarkar S, Gupta MS. Antibiotic resistance pattern of Enterococci isolates from nosocomial infections in a tertiary care hospital in Eastern India. J Nat Sci Biol Med. 2015;6(2):394-7. [PubMed ID: 26283837]. [PubMed Central ID: PMC4518417]. https://doi.org/10.4103/0976-9668.160018.

  • 31.

    Toru M, Beyene G, Kassa T, Gizachew Z, Howe R, Yeshitela B, et al. Prevalence and phenotypic characterization of Enterococcus species isolated from clinical samples of pediatric patients in Jimma University Specialized Hospital, south west Ethiopia. BMC Res Notes. 2018;11(1):281. [PubMed ID: 29739441]. [PubMed Central ID: PMC5941600]. https://doi.org/10.1186/s13104-018-3382-x.

  • 32.

    Bhatt P, Patel A, Sahni AK, Praharaj AK, Grover N, Chaudhari CN, et al. Emergence of multidrug resistant enterococci at a tertiary care centre. Med J Armed Forces India. 2015;71(2):139-44. [PubMed ID: 25859076]. [PubMed Central ID: PMC4388963]. https://doi.org/10.1016/j.mjafi.2014.08.007.

  • 33.

    Saifi M, Pourshafie MR, Eshraghian MR, Soltan Dallal MM. Anti-microbial resistance of Enterococci isolated from urinary tract infections in Iran. Iran Biomed J. 2008;12(3):185-90. [PubMed ID: 18762823].

  • 34.

    Ghasemi A, Moniri R, Musavi GA. The survey of multi drug resistant of Enterococcus faeciumisolated from clinical samples in shahid Beheshti and Shabeeh khani hospitals. Iran J Med Microbiol. 2009;3(2):21-6.

  • 35.

    Esmail MAM, Abdulghany HM, Khairy RM. Prevalence of multidrug-resistant enterococcus faecalis in hospital-acquired surgical wound infections and bacteremia: concomitant analysis of antimicrobial resistance genes. Infect Dis (Auckl). 2019;12:1178633719882930. [PubMed ID: 31662606]. [PubMed Central ID: PMC6796195]. https://doi.org/10.1177/1178633719882929.

  • 36.

    Ghalavand Z, Alebouyeh M, Ghanati K, Azimi L, Rashidan M. Genetic relatedness of the Enterococcus faecalis isolates in stool and urine samples of patients with community-acquired urinary tract infection. Gut Pathog. 2020;12:42. [PubMed ID: 32944085]. [PubMed Central ID: PMC7488108]. https://doi.org/10.1186/s13099-020-00380-7.

  • 37.

    Maraki S, Mantadakis E, Michailidis L, Samonis G. Changing antibiotic susceptibilities of community-acquired uropathogens in Greece, 2005-2010. J Microbiol Immunol Infect. 2013;46(3):202-9. [PubMed ID: 22795650]. https://doi.org/10.1016/j.jmii.2012.05.012.

  • 38.

    Ma KL, Wang CX. Analysis of the spectrum and antibiotic resistance of uropathogens in vitro: results based on a retrospective study from a tertiary hospital. Am J Infect Control. 2013;41(7):601-6. [PubMed ID: 23352074]. https://doi.org/10.1016/j.ajic.2012.09.015.

  • 39.

    Singhal A, Sharma R, Jain M, Vyas L. Hospital and community isolates of uropathogens and their antibiotic sensitivity pattern from a tertiary care hospital in North West India. Ann Med Health Sci Res. 2014;4(1):51-6. [PubMed ID: 24669331]. [PubMed Central ID: PMC3952297]. https://doi.org/10.4103/2141-9248.126611.

  • 40.

    Kiffer CR, Mendes C, Oplustil CP, Sampaio JL. Antibiotic resistance and trend of urinary pathogens in general outpatients from a major urban city. Int Braz J Urol. 2007;33(1):42-8. discussion 49. [PubMed ID: 17335597]. https://doi.org/10.1590/s1677-55382007000100007.

  • 41.

    del Campo R, Ruiz-Garbajosa P, Sanchez-Moreno MP, Baquero F, Torres C, Canton R, et al. Antimicrobial resistance in recent fecal enterococci from healthy volunteers and food handlers in Spain: genes and phenotypes. Microb Drug Resist. 2003;9(1):47-60. [PubMed ID: 12705683]. https://doi.org/10.1089/107662903764736346.

  • 42.

    Farman M, Yasir M, Al-Hindi RR, Farraj SA, Jiman-Fatani AA, Alawi M, et al. Genomic analysis of multidrug-resistant clinical Enterococcus faecalis isolates for antimicrobial resistance genes and virulence factors from the western region of Saudi Arabia. Antimicrob Resist Infect Control. 2019;8:55. [PubMed ID: 30962917]. [PubMed Central ID: PMC6434864]. https://doi.org/10.1186/s13756-019-0508-4.

  • 43.

    Rehman MA, Yin X, Zaheer R, Goji N, Amoako KK, McAllister T, et al. Genotypes and phenotypes of enterococci isolated from broiler chickens. Front Sustain Food Syst. 2018;2. https://doi.org/10.3389/fsufs.2018.00083.

  • 44.

    Zalipour M, Esfahani BN, Havaei SA. Phenotypic and genotypic characterization of glycopeptide, aminoglycoside and macrolide resistance among clinical isolates of Enterococcus faecalis: a multicenter based study. BMC Res Notes. 2019;12(1):292. [PubMed ID: 31133071]. [PubMed Central ID: PMC6537152]. https://doi.org/10.1186/s13104-019-4339-4.

  • 45.

    Feizabadi MM, Shokrzadeh L, Sayady S, Asadi S. Transposon Tn5281 is the main distributor of the aminoglycoside modifying enzyme gene among isolates of Enterococcus faecalis in Tehran hospitals. Can J Microbiol. 2008;54(10):887-90. [PubMed ID: 18923558]. https://doi.org/10.1139/w08-073.

  • 46.

    Heidari H, Hasanpour S, Ebrahim-Saraie HS, Motamedifar M. High incidence of virulence factors among clinical Enterococcus faecalis isolates in Southwestern Iran. Infect Chemother. 2017;49(1):51-6. [PubMed ID: 28332345]. [PubMed Central ID: PMC5382050]. https://doi.org/10.3947/ic.2017.49.1.51.

  • 47.

    Gaglio R, Couto N, Marques C, de Fatima Silva Lopes M, Moschetti G, Pomba C, et al. Evaluation of antimicrobial resistance and virulence of enterococci from equipment surfaces, raw materials, and traditional cheeses. Int J Food Microbiol. 2016;236:107-14. [PubMed ID: 27467501]. https://doi.org/10.1016/j.ijfoodmicro.2016.07.020.

  • 48.

    Gulhan T, Boynukara B, Ciftci A, Sogut MU, Findik A. Characterization of Enterococcus faecalis isolates originating from different sources for their virulence factors and genes, antibiotic resistance patterns, genotypes and biofilm production. Iran J Vet Res. 2015;16(3):261-6. [PubMed ID: 27175186]. [PubMed Central ID: PMC4782695].

  • 49.

    Hallgren A, Claesson C, Saeedi B, Monstein HJ, Hanberger H, Nilsson LE. Molecular detection of aggregation substance, enterococcal surface protein, and cytolysin genes and in vitro adhesion to urinary catheters of Enterococcus faecalis and E. faecium of clinical origin. Int J Med Microbiol. 2009;299(5):323-32. [PubMed ID: 19042153]. https://doi.org/10.1016/j.ijmm.2008.10.001.

  • 50.

    Barbosa-Ribeiro M, De-Jesus-Soares A, Zaia AA, Ferraz CC, Almeida JF, Gomes BP. Antimicrobial Susceptibility and Characterization of Virulence Genes of Enterococcus faecalis Isolates from Teeth with Failure of the Endodontic Treatment. J Endod. 2016;42(7):1022-8. [PubMed ID: 27221594]. https://doi.org/10.1016/j.joen.2016.03.015.

  • 51.

    Ferguson DM, Talavera GN, Hernandez LA, Weisberg SB, Ambrose RF, Jay JA. Virulence genes among enterococcus faecalis and enterococcus faecium isolated from coastal beaches and human and nonhuman sources in Southern California and Puerto Rico. J Pathog. 2016;2016:3437214. [PubMed ID: 27144029]. [PubMed Central ID: PMC4842068]. https://doi.org/10.1155/2016/3437214.

  • 52.

    Kafil HS, Mobarez AM. Spread enterococcal surface protein in antibiotic resistant Enterococcus faecium and Enterococcus faecalis isolates from urinary tract infections. Open Microbiol J. 2015;9:14-7. [PubMed ID: 26161154]. [PubMed Central ID: PMC4493631]. https://doi.org/10.2174/1874285801509010014.

  • 53.

    Niu H, Yu H, Hu T, Tian G, Zhang L, Guo X, et al. The prevalence of aminoglycoside-modifying enzyme and virulence genes among enterococci with high-level aminoglycoside resistance in Inner Mongolia, China. Braz J Microbiol. 2016;47(3):691-6. [PubMed ID: 27268115]. [PubMed Central ID: PMC4927675]. https://doi.org/10.1016/j.bjm.2016.04.003.

  • 54.

    Yang JX, Li T, Ning YZ, Shao DH, Liu J, Wang SQ, et al. Molecular characterization of resistance, virulence and clonality in vancomycin-resistant Enterococcus faecium and Enterococcus faecalis: A hospital-based study in Beijing, China. Infect Genet Evol. 2015;33:253-60. [PubMed ID: 25976380]. https://doi.org/10.1016/j.meegid.2015.05.012.

  • 55.

    Khorshidi A. Characterization of virulence genes in typical and atypical enteropathogenic Escherichia coli. J Sci Res Essay. 2011;6(31). https://doi.org/10.5897/sre11.1763.